Optogenetic control of electromechanical coupling in vascular smooth muscle cells (VSMCs) is emerging as a powerful research tool with potential applications in drug discovery and therapeutics. However, the precise ionic mechanisms involved in this control remain unclear.
Introduction
Optogenetics is an experimental approach involving the use of light in conjunction with microbial opsins (light-sensitive proteins) to control cell, tissue or organ function Lin, 2011; Entcheva, 2013) . For instance, cells engineered to express the non-selective, blue light-activated cation channel channelrhodopsin-2 (ChR2) can be controlled for excitability with exceptional spatio-temporal accuracy Lin, 2011; Entcheva, 2013) . The ChR2 channel is permeable to monovalent and divalent cations, including H + , Na + and Ca 2+ . Thus, opening of ChR2 channels typically leads to cell membrane potential (V m ) depolarization (Nagel et al., 2003; Caldwell et al., 2008; Lin, 2011) . Several ChR2 variants have been generated, including ChR2(H134R), characterized by reduced current desensitization and enhanced photocurrents as a consequence of the replacement of histidine at position 134 by arginine Lin, 2011; Reinbothe et al., 2014; Bruegmann et al., 2015; Wu et al., 2015) . ChR2 and its variants have been used extensively as experimental tools in the field of neuroscience to define brain circuitry (Boyden et al., 2005; Zhang et al., 2007; Yizhar et al., 2011) . These opsins have also been harnessed to control the function of non-neuronal cell types. For example, ChR2 has enabled control of myocardial excitability and inotropy (Arrenberg et al., 2010; Bruegmann et al., 2010; Entcheva, 2013) and skeletal muscle contraction (Asano et al., 2012; Sakar et al., 2012; Bruegmann et al., 2015) . Optogenetics has also the potential to revolutionize vascular research. An advance in this direction was recently made by Wu et al. (2015) , who selectively expressed a ChR2 mutant in murine vascular smooth muscle cells (VSMCs) to achieve optogenetic control of VSMC contraction and hence arterial tone. In their study, isolated aortic VSMCs expressing ChR2 channels demonstrated blue light-induced currents. The tone of isolated mesenteric artery rings increased in response to high-intensity blue light stimuli (ranging from 10 to 24 mW·mm À2 ), which were reported to evoke maximal ChR2 channel activation (Lin et al., 2009; Mattis et al., 2011) . Furthermore, it was possible to optogenetically modulate the perfusion pressure of the coronary and renal circulations in isolated hearts and kidneys (Wu et al., 2015) . Optogenetics has also been used to gain insights into the role of arterioles and pericyte-covered capillaries in the control of cerebral blood flow (Hill et al., 2015) . These important studies have demonstrated the utility and potential of optogenetics in vascular research. Critically important mechanistic aspects, however, need to be addressed to enable a complete interpretation of vascular optogenetics experiments and to exploit this technology in an in vivo setting. This technology has the potential of offering new approaches to the identification and testing of new compounds that could relieve vasoconstriction.
To provide a more complete and comprehensive mechanistic appraisal of vascular optogenetics, it is critical to probe arterial responses over an adequately wide range of light stimulations to determine whether different degrees of ChR2 activation produce fine, graded control of vessel tone. Furthermore, it is well established that isolated wild-type mammalian systemic arteries pre-constricted with agonists, such as noradrenaline or phenylephrine, relax in response to blue light in a ChR2-independent manner (Furchgott et al., 1955; Ehrreich and Furchgott, 1968; Sikka et al., 2014) . Blue light-mediated relaxation was also observed in murine cerebral arterioles in situ (Rungta et al., 2017) . Thus, evaluating the capacity of ChR2-induced contraction to overcome the intrinsic blue light-dependent arterial relaxation is an essential prerequisite for establishing vascular optogenetics in vivo, where the circulating levels of catecholamines will vary depending on the extent of the sympathetic drive. It is also important to explain the precise ionic mechanisms linking light stimulation with arterial contraction. This includes an understanding of the extent to which ChR2 channel opening evokes depolarization and activates endogenous channels, as opposed to providing a direct route for non-physiological Ca 2+ entry. A related point is to assess possible changes in intracellular pH (pH i ) of VSMCs, which may occur as a consequence of prolonged ChR2 activation due to its permeability to H + (Nagel et al., 2003; Lin et al., 2009; Berndt et al., 2010 Berndt et al., , 2011 Gradmann et al., 2011) . Lightevoked changes in pH i would be highly relevant because of their known modulatory effects on of excitation-contraction coupling and responses to pharmacological agents (Wakabayashi et al., 2006; Boedtkjer and Aalkjaer, 2012) . To address the issues outlined above, we generated mice expressing ChR2(H134R) selectively in VSMCs. We systematically examined the effects of a wide range (0.01-12.1 mW·mm À2 ) of blue light intensities on both the magnitude of ChR2(H134R) current in isolated VSMCs and the extent of contraction of artery rings. A broad range of artery type was included in these studies, namely, large conduit, small systemic and pulmonary arteries. In the case of isolated aortic VSMCs and isolated rings, experiments were extended to accurately map the effect of blue light on V m and on the ionic mechanisms involved in contraction. We found that expression of ChR2(H134R) channels enabled optical voltage clamp of these VSMCs. At blue light stimulations lower than 0. The use of transgenic mice was approved by the University Ethics Committee. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Mice expressing ChR2(H134R) tagged with the enhanced yellow fluorescent protein [ChR2(H134R)-eYFP] specifically in smooth muscle were generated and termed ChR2 (H134R)-SM mice. Mice engineered to harbour the ChR2 (H134R)-eYFP coding sequence within the Gt(ROSA)26Sor locus downstream of a STOP cassette were used as a control. Fuller descriptions of the mouse strains used (from Jackson Laboratories) are given in the Supporting Information. Mice (maximum six per cage) were housed in a pathogen-free environment in Tecniplast Sealsafe IVC cages (floor area 542 cm 2 ).
Treated Aspen chip and Sizzle-Nest bedding and environmental enrichment (such as play tunnels) were present in each cage. Mice were maintained in a 12 h light/dark cycle, in controlled temperatures (20-22°C) and fed normal chow and water ad libitum. For each genotype, mice of either sex were selected randomly on the day of the experiment. Adult mice aged 8-14 weeks were used in this study.
Cell fluorescence imaging
Confocal and epifluorescence microscopy was used to estimate the cellular distribution and degree of expression of ChR2(H134R) in freshly isolated VSMCs (aortic, mesenteric and pulmonary) respectively (Adomaviciene et al., 2013; McCloy et al., 2014) .
Electrophysiology
Ionic currents were recorded with the whole-cell configuration of the patch-clamp technique in isolated VSMCs. The V m was recorded with the perforated patch-clamp configuration during current clamp. Current recordings were normalized to cell capacitance to obtain current density (in pA·pF À1 ). Only cells with a seal resistance ≥1 GΩ were considered for analysis. Cells were exposed to pulses of blue light (470 nm wavelength) of 0.01-12.1 mW·mm À2 intensity.
Duration of the pulses was 2 s, unless stated otherwise. ChR2(H134R) currents were measured at À80 mV. The ChR2(H134R) current versus blue light intensity relationship was fitted with the Hill equation of the form:
where I is the steady-state ChR2(H134R) current density measured at a given light intensity, I max is the maximal asymptotic current reached, EL 50 is the light intensity causing half-maximal current activation and h is the slope coefficient. The small current observed in the dark was subtracted offline from the current measured at each light intensity. Thus, I represents the ChR2(H134R) blue light-activated current. The membrane potential (V m ) versus light intensity relationship was fitted with a modified Hill equation of the form:
where V m is the membrane potential, V rest is the resting V m (in the absence of light stimulation), V max is the maximal asymptotic V m reached, EL 50 is the light intensity causing half-maximal membrane depolarization and v is the slope coefficient.
The whole-cell current density versus voltage relationship for Ca V channels was obtained by applying 200 ms pulses from À70 to +60 mV in 5 mV steps from a holding potential (V hold ) of À60 mV. The peak current density was measured for each V m and plotted versus V m . The resulting relationship was fitted with a modified Boltzmann equation of the form:
where I p is the peak current density, G max is the whole-cell Ca 2+ conductance, V rev is the whole-cell current reversal potential, V 0.5,a is the midpoint voltage for current activation and s a is the e-fold slope. Steady-state inactivation properties were assessed by applying 1.5 s conditioning prepulses from À90 to +40 mV in 10 mV steps. Each prepulse was followed by a 200 ms test pulse to +10 mV. The V hold was À60 mV. The peak current (I p ) in response to each test pulse was measured, normalized for the maximal I p and plotted versus the V m of the prepulse. The resulting steady-state inactivation was fitted with a Boltzmann equation of the form:
where I max is the maximal current and V 0.5,h is the midpoint voltage for current inactivation and s h is the e-fold slope.
Myography
Contraction of isolated artery (aortic, mesenteric and pulmonary) rings was measured using a small vessel wire myograph (model 420A, Danish Myo Technology, Aarhus, Denmark). Tension measurements (in mN) were normalized for the artery ring length (in mm) to enable comparison of data obtained from rings of slightly different length. Tissue was stimulated with blue light of various intensities (0.02-7.21 mW·mm
À2
). Duration of the pulses was 7 min, unless stated otherwise.
The tension versus blue light intensity relationships in the absence of PE were fitted with the Hill equation of the form:
where T is the tension (normalized for length of the artery ring) measured at a given light intensity, T ss is the maximal asymptotic tension reached, EL 50 is the light intensity causing half-maximal tension and s is the slope coefficient. As outlined in the main text and shown in Figure 7 , the response of isolated aortic rings to phenylephrine was characterized by a rapid contraction followed by a transient relaxation and a slow increase in tension. Thus, phenylephrine did not induce a stable level of contraction. To account for this changing level of tension, in the experiments conducted in the presence of phenylephrine (Figure 4 ), the effect of each light stimulation on artery ring tension was expressed relative to the mean of the tension measured immediately before and after a given light exposure and the average data fitted using Equation 5.
Equation 5 was also used to quantify the tension versus extracellular KCl concentration ([KCl] e ) (Supporting Information Figure S1 ) or noradrenaline concentration ([NA]) (Supporting Information Figure S3 ) relationships. In these cases, the independent variable was [KCl] 
pH imaging
Freshly isolated aortic VSMCs were loaded with cSNARF1 (10 μM of its AM-ester for 10 min) and imaged for pH ratiometrically (Zeiss LSM confocal system; excitation 555 nm, emission collected simultaneously at 580 and 640 nm). Ratio was converted to pH i using a calibration curve determined in separate experiments by nigericin clamping of pH i . pH i was measured before and after 7 min exposure of blue light of various intensities (0.03-2.1 mW·mm À2 ).
Blue light stimulation systems for optogenetics
In patch-clamp experiments, optical stimulation of ChR2 (H134R)-expressing VSMCs was performed using an optoLED system (Cairn Research, Kent, UK), comprising of a 3.5 W blue light (470 nm)-emitting diode (LED) mounted on the rear port of an inverted microscope (IX51, Olympus, Southend-on-Sea, UK). The optoLED system was controlled by GePulse software (Dr M. Pusch, CNR, Italy) with an analogue-to-digital and digital-to-analogue converter (USB-6221; National Instruments, Newbury, UK).
For myography experiments, blue light was provided by a 5 W LED, controlled by a power supply made in-house (Mr M. Preston, Dept. Pharmacology, University of Oxford) and delivered through a glass window positioned at the bottom of the myography bath chambers. Intensity and duration of the stimulus were digitally controlled. In pH imaging experiments, the same LED power supply system was used, and blue light was delivered to the sample through a liquid light guide with a core diameter of 3.0 mm (Newport, Irvine, CA, USA), reaching the sample on the microscope stage perpendicularly from above.
Light intensity (in mW·mm À2 ) was measured at the sample (cell or tissue) site using a Newport digital optical power meter (Model 843, Newport), with a sensor area of 0.4 × 0.4 cm, with wavelength set at 470 nm. Calibration performed at the beginning of the experiments confirmed that the LED current (in the range 0-1.0 A) was linearly related to the illumination wattage at the sample plane.
Blinding
It was not feasible for the operator to be blinded to the genotype of the mice used during each individual experiment as the absence or presence of the effects assessed (such as the ionic current or force of contraction), immediately revealed the genotype of the sample under examination. The methods of analysis were established during study design, and prior to execution of the experiments, to remove possible operator bias.
Data and statistical analysis
The data and statistical analysis in this study comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015 
Materials
Compounds used in the experiments described here were supplied as follows: nifedipine, noradrenaline, phenylephrine and ryanodine by Sigma-Aldrich (Gillingham, Dorset, UK); 2-aminoethoxydiphenyl borate (2-APB), Ani9, clotrimazole and MONNA by Tocris (Abingdon, Oxfordshire, UK).
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology. org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a,b,c) .
Results

ChR2(H134R) expression and current density in VSMCs
To assess the utility of vascular optogenetics in different vascular beds, we determined the degree of ChR2(H134R) expression in various artery types obtained from ChR2(H134R)-SM mice, as this may influence the arterial sensitivity to blue light stimuli. VSMCs (from aortic, mesenteric and pulmonary arteries) were isolated from control and ChR2(H134R)-SM mice and imaged confocally to assess ChR2(H134R) distribution within the cell ( Figure 1A -C). VSMCs obtained from ChR2(H134R)-SM mice had prominent eYFP signal demonstrating expression of the channel construct ( Figure 1A ). The fluorescence signal was primarily detected in the plasma membrane of VSMCs ( Figure 1B ), as indicated by the eYFP intensity profiles (along the solid white lines in Figure 1A ). In contrast, no detectable fluorescence was identified in VSMCs isolated from control mice ( Figure 1A ). To obtain a measure of the total ChR2(H134R) expression in the various VSMCs types, the average eYFP fluorescence intensity was assessed by epifluorescence microscopy and normalized for cell area (fluorescence density). The fluorescence density in mesenteric VSMCs was about~0.5 that of the aortic VSMCs, while the intensity of pulmonary artery VSMCs was indistinguishable from that of the aortic VSMCs ( Figure 1C ). To test if differences in ChR2(H134R) expression affected the current density, whole-cell currents were recorded from aortic, mesenteric and pulmonary VSMCs isolated from ChR2(H134R)-SM mice. As observed with ChR2(H134R) currents in heterologous expression systems Lin et al., 2009; Berndt et al., 2011) , ChR2(H134R) currents in isolated VSMCs were characterized by a rapid activation followed by a rapid inactivation to a new steady-state level ( Figure 1D ). The steady-state current increased as light intensity was increased. The fit of the steady-state current density versus blue light intensity relationships with Equation 1 yielded a maximal asymptotic current (I max ) of approximately À18, À9 and À22 pA·pF À1 for aortic, mesenteric and pulmonary VSMCs respectively ( Table 1 ). The light intensity causing half-maximal effect (EL 50 ) was~0.3-mW·mm À2 , and the slope factor (h) was~0.6-0.8 in each case (Table 1) . Thus, different expression levels of ChR2 (H134R) resulted in currents with different amplitudes (I max ), but of similar sensitivity to blue light, quantified in terms of parameters EL 50 and h. In contrast, there was essentially no current increase observed in VSMCs obtained from control mice. For instance, the current in the presence of 12.1 mW·mm 
Relationship between blue light intensity and tension in isolated artery rings
To examine the precise relationship between the ChR2 (H134R) current amplitude and changes in arterial tone, isometric tension measurements were performed in isolated aortic, mesenteric and pulmonary artery rings obtained from ChR2(H134R)-SM mice. Isolated artery rings were exposed to periods (7 min) of blue light illumination of various intensities. The tension of the arterial rings increased as the blue light intensity increased (Figure 2A, B) . The maximal level of contraction was reached in blue light intensities of >0.7-mW·mm À2 in aortic and pulmonary artery rings, whereas the mesenteric artery rings required blue light >2 mW·mm À2 to achieve maximal contraction. Figure S1 ). Thus, all artery types tested demonstrated maximal or near-maximal tension at the highest levels of ChR2(H134R) activation.
Relationship between duration of blue light exposure and tension of isolated artery rings
Experiments shown in Figure 2A illustrate that prolonged exposure (7 min) of isolated artery rings to blue light produced stable contractions. We next tested if shorter pulses of blue light could initiate contraction of isolated artery rings or whether the blue light stimulation had to be maintained in order to achieve steady-state contraction. Aortic rings isolated from ChR2(H134R)-SM mice were exposed to light of 0.23 mW·mm À2 for various time periods Table 1 Parameters for the current versus blue light intensity relationships for VSMCs obtained from ChR2(H134R)-SM mice
ChR2(H134R)-SM mice
Aorta
Mesenteric artery Pulmonary artery EL 50 (mW·mm À2 ) 0.31 ± 0.03 (N = 10, n = 18) 0.32 ± 0.02 (N = 6, n = 16) 0.37 ± 0.04 (N = 7, n = 23) h 0.8 ± 0.1 (N = 10, n = 18) 0.6 ± 0.1 (N = 6, n = 16) 0.8 ± 0.1 (N = 7, n = 23)
solution was supplemented with 50 mM KCl, as this was expected to produce V m depolarization to approximately À25 mV (Nelson and Quayle, 1995; Aidley, 1998) . Aortic rings were exposed to elevated [KCl] e for 1 or 7 min. Note that, in these experiments, solution exchange in the myography chamber required~1 s and thus, KCl application for 2 s was not attempted. Application of 50 mM KCl for 1 or 7 min led to an increase in artery tension to 2.2 ± 0.2 mN·mm À1 (N = 5) and 3.4 ± 0.4 mN·mm À1 (N = 5), respectively. Washout with PSS resulted in immediate onset of relaxation. In addition to the comparable levels of contraction achieved, the time course of blue light-induced and KCl-induced contractions was very similar, and each followed a double exponential time course, with a fast (τ f ) and slow (τ s ) component. These components were quantifiable during the long (7 min) stimulations. KCl stimulation was associated with τ f of 7.7 ± 1.4 s (N = 5) and a τ s of 122 ± 16 s (N = 5), whereas light stimulation was characterized by τ f of 5.0 ± 0.7 s (N = 5) and τ s of 117 ± 19 s (N = 5). These experiments showed that in agreement with the well-established contractile effect of elevated [KCl] e , blue light stimulation also needed to be continuously maintained in order to sustain aortic smooth muscle contraction. Effect of ChR2(H134R) activation on the V m of isolated VSMCs
As outlined in the previous section, changes in arterial tone are expected to be linked to changes in V m (Nelson et al., 1990) . To quantitatively define the effects of ChR2(H134R) on the V m of aortic VSMC, the perforated-patch configuration in current-clamp mode was used. The resting V m of ChR2(H134R)-SM aortic VSMCs was À40.2 ± 1.6 mV (N = 13), which was not significantly different from the resting V m of VSMCs obtained from control mice (À42.2 ± 2.2 mV, N = 5) ( Figure 3A, B) . In response to light stimulations of up to 12.1 mW·mm À2 , the membrane depolarized to À21.5 ± 1.3 mV (N = 11) in aortic VSMCs isolated from ChR2(H134R)-SM mice (Figure 3 ). Cessation of light stimulation resulted in a prompt return to resting V m ( Figure 3A ). The fit of the V m versus light intensity Channelrhodopsin-2 in vascular optogenetics relationship with Equation 2 yielded an EL 50 of 0.2 ± 0.1 mW·mm À2 (N = 11), a slope factor (v) of 0.6 ± 0.1 (N = 11) and the maximal asymptotic V m (V max ) of À16.2 ± 2.6 mV (N = 11). In contrast, the V m of aortic VSMCs obtained from control mice was not significantly affected by blue light ( Figure 3A, B) . Thus, the V m of isolated aortic VSMCs expressing ChR2(H134R) can be optically clamped by exposure to blue light. As outlined above, ChR2(H134R)-mediated contraction of isolated aortic rings required continuous, prolonged exposures to blue light. Thus, the suitability of ChR2(H134R) to maintain V m depolarization for prolonged periods of time (7 min) was also tested. The V m of isolated aortic VSMCs in response to 0.22 mW·mm À2 , an intensity that produced half-maximal depolarization, remained clamped to approximately À27 mV during the 7 min illumination period ( Figure 3C ). This effect was quantified by measuring the V m in the first and seventh minute of blue light exposure: no significant change in V m was detected ( Figure 3D ). V m depolarization is expected to lead to activation of Ca v channels, increased Ca 2+ influx and VSMC contraction (Knot et al., 1996; Gollasch and Nelson, 1997; Jackson, 2000) . To define the precise relationship between ChR2(H134R)-induced depolarization and extent of Ca v channel activation in our model, the voltage dependence of Ca v channel activation and inactivation was determined in aortic VSMCs isolated from ChR2(H134R)-SM mice (Supporting Information Figure S2 ). The steady-state activation curve was characterized by a half-activation potential (V 0.5,act ) of 0.1 ± 2.0 mV (N = 8) and a slope factor (s a ) of 8.9 ± 0.6 mV (N = 8). The steady-state inactivation curve was characterized by a half-inactivation potential (V 0.5,inact ) of À34.1 ± 1.4 mV (N = 7) and a slope factor (s i ) of 11.5 ± 1.1 mV (n = 7). Window currents, the range of V m in which Ca v channels are active, spanned between approximately À40 and approximately +10 mV (Supporting Information Figure S2B ). Thus, V m depolarization due to ChR2(H134R) activation shifted the V m from a resting value of approximately À40 mV, to values that fall within the window current range of Ca v channels.
Effects of light in the presence of phenylephrine
The isolated artery ring experiments described above were performed in the absence of contractile agonists, such as phenylephrine . As outlined in the Introduction, in the presence of contractile agents, isolated wild-type arterial smooth muscle has been reported to relax in response to blue light (Furchgott et al., 1955; Ehrreich and Furchgott, 1968; Sikka et al., 2014) . The next set of experiments aimed to test whether ChR2(H134R)-mediated depolarization and contraction could overcome the relaxing response of arteries to blue light. We began by quantifying the relaxation of aortic rings obtained from control mice in response to blue light. In the presence of phenylephrine (1 μM), aortic rings relaxed in a blue light intensity-dependent manner ( Figure 4A ). To establish whether opening of ChR2(H134R) was sufficient to counteract the relaxation described above, aortic rings isolated from ChR2(H134R)-SM mice were exposed to blue light of increasing intensities in the presence of phenylephrine (1 μM). Under these conditions, aortic rings contracted in response to blue light ( Figure 4A ). For example, blue light of 0.72 mW·mm À2 elicited a~3.5 mN·mm À1 increase in tension ( Figure 4B ). The fit of the tension versus blue light intensity relationship with Equation 5 yielded an EL 50 of 0.1 ± 0.1 mW·mm À2 (N = 5), a slope factor (s n ) of 0.9 ± 0.1 (N = 5) and a T ss of 3.8 ± 0.6 mN·mm À1 (N = 5).
Ionic mechanisms of ChR2(H134R)-induced artery contraction
The next series of myography experiments were conducted to characterize the ionic mechanism(s) underlying the ChR2(H134R)-mediated contraction of aortic rings. To determine whether blue light-induced contraction required influx of Ca 2+ from the extracellular fluid, aortic rings obtained from ChR2(H134R)-SM mice were exposed to blue light in Ca 2+ -free PSS. Under these conditions, blue light stimulation produced a very small contraction. For example, the tension measured during 7.21 mW·mm À2 blue light stimulation was 0.1 ± 0.1 mN·mm À1 (N = 5) compared with 4.0 ± 0.1 mM·mm
À1
(N = 32) in the presence of extracellular Ca 2+ ( Figure 5A ).
The contraction of isolated aortic rings was dramatically reduced by application of the Ca v channel blocker nifedipine at a concentration (1 μM) that blocks L-type Ca 2+ channels fully ( Figure 5B ) (Brayfield, 2014) . Nifedipine shifted the EL 50 of the tension versus light intensity relationship from 0.1 to~0.8 mW·mm À2 , and the slope factor (s) slightly increased from~1.5 to~2, while the maximal tension achieved (T ss ) remained unaltered (~3.6 mN·mm À1 ) ( Figure S1 ). Nifedipine is a light-sensitive compound that photodegrades into a 2-nitroso derivative when exposed to daylight (Brayfield, 2014) . Therefore, the possibility that nifedipine was degraded during exposure to blue light was examined via a separate set of functional electrophysiological experiments. The extracellular whole-cell patch-clamp solution containing nifedipine (1 μM) was illuminated with highintensity blue light (2.4 mW·mm À2 ) for 10 min. The extent to which Ca v current in isolated aortic VSMCs was inhibited by this solution was indistinguishable from that caused by a nifedipine-containing solution that was not exposed to light (Supporting Information Figure S2C ). Thus, exposure of nifedipine to blue light did not alter its inhibitory effect on Ca V channels in these experiments. The isometric tension recordings described above demonstrated that in response to light stimulations below 0.1 mW·mm À2 , aortic ring contraction required Ca v channel activation. Presumably contractions triggered by blue light stimulations of greater power would involve, at least in part, Ca 2+ influx through ChR2(H134R) and would result in a level of contraction, which may not be reached under normal physiological conditions. To evaluate the maximal degree of tension that the artery may develop in vivo, we examined the response of isolated aortic artery rings to the physiological agonist noradrenaline. Supporting Information Figure S3 shows that the maximal tension triggered by this agonist was~2. (Ito et al., 1986) . Figure 5C illustrates that this intervention did not significantly affect the arterial response to blue light. The contribution of inositol trisphosphate (IP 3 ) to CICR was also tested by incubating vessels in 2-aminoethoxydiphenyl borate (2-APB) (60 μM). The CaCC coded by the Tmem16a gene represents a key depolarizing mechanism in vascular smooth muscle (Manoury et al., 2010; Bulley and Jaggar, 2014; Hübner et al., 2015; Matchkov et al., 2015) . CaCCs in VSMCs are typically activated by IP 3 -mediated Ca 2+ release (Manoury et al., 2010; Bulley and Jaggar, 2014; Hübner et al., 2015; Matchkov et al., 2015) . To investigate whether TMEM16A channels participate in the blue light-induced contraction in arteries obtained from ChR2(H134R)-SM mice, the TMEM16A inhibitors MONNA (3 μM) (Oh et al., 2013) or Ani9 (1 μM) (Seo et al., 2016) were added to the PSS. Pharmacological blockade of TMEM16A channels with these agents significantly reduced the contractile response to blue light stimulation by~0.5-fold and~0.3-fold at 0.02 and 0.07 mW·mm À2 respectively ( Figure 5D ). Another Ca 2+ -activated depolarizing channel types in VSMCs are the TRPM channels (Guibert et al., 2011) . Their involvement was tested by inhibiting them using the TRPM blocker clotrimazole (10 μM) (Zholos, 2010) . This caused significant reduction of blue light-induced contraction by up to~0.7-fold ( Figure 5E ). The less selective channel blocker 9-phenanthrol (50 μM), which blocks TRPM and TMEM16A channels caused up to~0.8-fold reduction of contraction ( Figure 5E ).
Blue light evoked changes in intracellular pH
As ChR2(H134R) is a ion channel highly permeable to H + , prolonged activation may lead to a net transmembrane H + flux and changes in pH i . To test this, pH i was measured in
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isolated aortic VSMCs obtained from ChR2(H134R)-SM and control mice before and after 7 min light stimulation of various intensities ( Figure 6 ). The pH i prior to light stimulation was 6.9 ± 0.1 (N = 5) in cells isolated from ChR2(H134R)-SM mice. In VSMCs isolated from control mice, the starting pH i was 6.8 ± 0.1 (N = 5). Figure 6 shows that no significant change in pH i was observed at lowintensity blue light (<0.1 mW·mm À2 ). At higher intensities, however, the light protocol evoked significant alkalinization of the cytoplasm, by up to~0.25 pH units ( Figure 6B ).
Comparison of light-induced and agonist-induced contraction
The previous sets of experiments identified the range of blue light intensities within which ChR2(H134R) activation resulted in VSMCs depolarization, Ca v and TMEM16A channel activation and arterial contraction in the absence of pronounced changes in pH i or Ca 2+ entry through ChR2(H134R). We examined the contractile response of isolated aortic rings to prolonged (25 min) stimulation with a light intensity (0.05 mW·mm À2 ), which falls within this range. The response was then compared with those elicited by contractile agonists such as phenylephrine (0.4 μM) and noradrenaline (10 μM). These agonist concentrations were selected as they evoked an average contraction of 1.4 ± 0.1 mN·mm À1 (noradrenaline, N = 5) and 1.1 ± 0.1 mN·mm À1 (phenylephrine, N = 5), which were comparable with a tension of 1.2 ± 0.1 mN·mm À1 (N = 5) induced by 0.05 mW·mm À2 blue light. Blue light stimulation triggered a contraction that rapidly reached a maximal, stable steady-state value. In contrast, noradrenaline produced a transient contraction followed by fluctuating levels of tension ( Figure 7A ). Phenylephrine -induced contraction was characterized by a peak followed by a slow drop and then subsequent rise in tension. The nadir to peak ratio measured in each artery ring was used as a measure of the stability of the tension induced by the various stimuli. This ratio was 0.9 ± 0.1 (N = 5), 0.4 ± 0.1 (N = 5) and 0.7 ± 0.1 (N = 5) for blue light, noradrenaline and phenylephrine respectively ( Figure 7B ). Table 3 Parameters for the tension versus blue light relationships for aortic rings obtained from ChR2(H134R)-SM mice in the presence of nifedipine
Parameters (EL 50 , s and T max ) obtained from the Hill fit (Equation 5) of the tension versus blue light intensity relationship for aortic rings obtained from ChR2(H134R)-SM mice. *P < 0.05,significantly different from data without nifedipine, shown in Table 2 ; Student's t-test. Thus, blue light stimulation produced a more stable response than those to the contractile agonists.
Discussion
This study provides a comprehensive analysis of the blue light sensitivity of isolated VSMCs and artery rings obtained from ChR2(H134R)-SM mice. Activation of the ChR2(H134R) channels caused V m depolarization, activation of Ca v , TMEM16A and TRPM channels. In intact artery rings, this resulted in an increase in artery tone. In the presence of blue light of intensities <0.1 mW·mm À2 , the artery ring contraction was completely prevented by nifedipine. This indicated that Ca v channel activation was mandatory for contraction in response to blue light intensities. Within this light intensity range, TMEM16A and TRPM channels and IP 3 receptors contributed to the contractile response. Furthermore, the pH i remained stable. In contrast, light stimuli greater than 0.1 mW·mm À2 led to contractions, even in the presence of Ca v channel blockade, suggesting that significant Ca 2+ influx through ChR2(H134R) channels might be occurring. In addition, the pH i of isolated aortic VSMCs was significantly alkalinized. Thus, this study determined the range of light intensities (<0.1 mW·mm À2 ) that enabled modulation of the V m and artery tone of ChR2(H134R)-SM mice primarily via recruitment of endogenous channels while minimizing any disturbances to pH i . This experimental analysis demonstrates the ChR2(H134R)-SM mice as a powerful experimental model to selectively control the excitability of VSMCs.
ChR2(H134R) expression and current amplitude in isolated VSMCs
The level of ChR2(H134R) expression in VSMCs decreased in the order pulmonary artery ≈ aorta > mesenteric artery. The amplitude of the current density also followed this order.
Possible causes of different ChR2(H134R) protein expression in different VSMC types include (i) variable levels of transcription factors acting on the transgelin promoter, which in turn controls the expression of the Cre recombinase and/or (ii) differences in how proteins are trafficked and expressed in different VSMCs types. Regardless of the underlying causes of variable expression of ChR2(H134R) in different artery types, the degree of expression in the arteries tested was sufficient to allow maximal or near-maximal contraction in all artery types tested. The time course of the change in tension of aortic rings in response to blue light or elevated [KCl] e was remarkably similar. Furthermore, continuous application of either stimulus was necessary for the tension of isolated aortic rings to reach a maximal, steady-state value. These observations suggest that activated ChR2(H134R) channels acted as a depolarizing mechanism (providing an 'optical voltage-clamp' method) in a similar way to high [KCl] which could lead to an alteration in the intracellular Na + concentration. In turn, this may affect other secondary transport mechanisms as well as the action of numerous enzymes and intracellular proteins (Page and Di Cera, 2006) .
ChR2(H134R)-induced and agonist-induced contraction of isolated artery rings
Earlier studies have indicated that systemic arteries obtained from wild-type animals pre-constricted with noradrenaline or phenylephrine, relaxed in response to blue light ( Furchgott et al., 1955; Ehrreich and Furchgott, 1968; Sikka et al., 2014) . A key mechanism involved in this response was the activation of melanopsin (OPN4) receptors (Sikka et al., 2014) . Dilation in response to blue light was also observed in murine cerebral arterioles although the molecular mechanism and signalling pathway involved in photodilation in this circulation remains unclear (Rungta et al., 2017) . We have determined that ChR2(H134R)-mediated contraction overcame the native relaxation in murine systemic arteries in response to blue light. This is a prerequisite for the use of vascular optogenetic in vivo as the arteries are exposed to varying levels of circulating or locally released catecholamines, depending on the extent of sympathetic stimulation. This information indicates a possible use of vascular optogenetics in vivo as a tool to control vessel tone. Isolated aortic artery rings obtained from ChR2(H134R)-SM mice responded to blue light with a stable contraction. In contrast, fluctuations of isolated artery tone were observed in response to receptor agonists such as phenylephrine or noradrenaline. This may have significant implications for pharmacology and drug discovery. The potency of new vasodilating compounds might be more difficult to assess in vessels pre-constricted with agents that elicit a changing level of vessel tone. This is because spontaneous variation in tone may complicate the quantification of the effects of vasodilating drugs. The stability of the blue light-induced contraction could therefore aid the assessment of new vasodilating drugs on isolated arteries.
Investigating the ionic mechanisms underlying ChR2(H134R)-induced artery contraction
Ca v channels are a principal and well-established route of Ca 2+ influx in VSMCs (Jackson, 2000; Cribbs, 2001) . In isolated aortic VSMCs, Ca v channel window currents spanned from approximately À40 to +10 mV while the resting V m was approximately À40 mV. This indicated that a small blue light-dependent depolarization from the resting V m was sufficient to bring the V m into a range where Ca v channels were active. Therefore, the ChR2(H134R) channels served, primarily, as a switch for Ca v channel activation. CICR mediated by IP 3 receptors but not RyR contributed to the blue light-induced artery contraction. This suggests that the ChR2(H134R) channels are not directly juxtaposed to RyRs in the endoplasmic reticulum. It is likely that 2-APB inhibits targets other than IP 3 R. Specifically, 2-APB may also inhibit TRP channels, including TRPC channels (Xu et al., 2005) . These channels however are activated by PIP 2 breakdown, which usually takes place in response to G q PCR stimulation (Gonzalez-Cobos and Trebak, 2010) . Thus, TRPC channels may not be fully active during the ChR2(H134R)-induced contraction and 2-APB may not be eliciting its actions via blockade of TRPC channels. Another off-target effect of 2-APB is the inhibition of gap junctions (Bai et al., 2006) . One of the most abundantly expressed connexins in smooth muscle is Cx43 (Figueroa and Duling, 2009) , which has relatively low sensitivity to 2-APB (IC 50 = 52 μM) (Bai et al., 2006 (Manoury et al., 2010; Bulley and Jaggar, 2014; Hübner et al., 2015; Matchkov et al., 2015) . Thus, TMEM16A opening may also contribute to the blue light-induced depolarization of VSMCs and arterial contraction. Our pharmacological analysis using clotrimazole indicated that Ca 2+ -activated TRPM channels also contributed to the blue light-induced contraction. Clotrimazole may also block intermediate conductance K + (IK Ca ) channels (Wulff et al., 2001) . These channels are especially expressed in endothelial cells (ECs), where they contribute to NO generation and endothelium-dependent hyperpolarization (Félétou, 2009 ). Thus, their inhibition would presumably enhance contraction and antagonize the reduction in blue light-induced contraction caused by this agent. Clotrimazole has also been shown to partially (20%) block cardiac Ca v channels (Thomas et al., 1999) . This may contribute to a small fraction of the effect of clotrimazole on light-induced contraction in aortic rings. The TRPM4 blocker 9-phenanthrol reduced the extent of contraction to a similar degree to clotrimazole. The pharmacology of TRPM channels is currently limited in terms of specificity, and 9-phenanthrol has recently been shown to also block TMEM16A channels (Burris et al., 2015) . However, the block seen with 9-phenanthrol is significantly greater than that observed with either MONNA or Ani9 suggesting a clear role for TRPM4 channels in blue light-induced contraction.
Blue light-driven intracellular alkalinization
The ChR2(H134R) channels are highly permeable to H + (Nagel et al., 2003; Lin et al., 2009; Berndt et al., 2010 Berndt et al., , 2011 Gradmann et al., 2011) . We demonstrated that prolonged activation of ChR2(H134R) channels in response to highintensity (>0.1 mW·mm À2 ) blue light stimulations produced intracellular alkalinization. These changes in pH i are consistent with the fact that the average equilibrium potential for H + (E H+ ) in the aortic VSMCs was approximately À29 mV under our experimental conditions, based on the Nernst equation for intracellular and extracellular pH of~6.9 and 7.4 respectively. Thus, when V m rises above À29 mV, as occurs VSMCs (Aalkjaer and Peng, 1997 ) is likely to offset any H + influx through ChR2(H134R) channels.
The effect of a change in pH i by >0.1 pH units can substantially alter the sensitivity of VSMCs to humoral factors (Wray and Smith, 2004; Wakabayashi et al., 2006; Boedtkjer and Aalkjaer, 2012; Boedtkjer et al., 2016) as well as affect VSMC migration (Boedtkjer et al., 2016) and gene transcription (Wakabayashi et al., 2006) . Thus, prolonged activation of ChR2(H134R) channels by high-intensity blue light in vivo may lead to a pH-dependent alteration in arterial histology and function.
Implications for vascular pharmacology and therapeutic drug discovery
Vascular optogenetics has many potential applications including serving as an experimental tool to control blood perfusion to specific organs or tissues (Wu et al., 2015) . Thus, organ ischaemia could be experimentally reproduced by inducing vessel constriction in vivo in experimental animals, potentially via the use of remotely controlled, wireless microLEDs implanted s.c. . This may lead to important implications for biomedical research by aiding the identification of new drugs or treatments that could counter ischaemia. As outlined above, the stable contraction obtained in isolated arteries may also facilitate drug testing ex vivo. At a single-cell level, the possibility of controlling V m optically could enable high-throughput screening of drugs at various V m , including depolarized V m typically associated with diseases of altered vessel tone (Platoshyn et al., 2000; Wellman et al., 2001) . It can be envisaged that viralmediated ChR2(H134R) expression could be obtained in cultured human cells to be used in drug testing. This may help reducing, and to an extent replacing, the use of animals during drug screening studies. Our study demonstrates that vascular optogenetics is especially viable within a welldefined range of blue light of low intensity within which activation of ChR2(H134R) channels serves merely as a switch for activation of other, endogenous, membrane transport mechanisms.
Vascular optogenetics has the potential to further our understanding of the physiological role of electrical coupling between different cell types (such as VSMCs and ECs) within the arterial wall. Investigating the electrical coupling between ECs and VSMCs in intact vessels has presented significant technical challenges. For instance, injection of current in ECs using sharp microelectrodes may result in non-uniform control of V m . Voltage clamping of cell membrane is also restricted by the limited current-passing ability of the microelectrodes. In addition, electrical stimulation may also initiate irreversible Faradaic reactions, potentially leading to the formation of gases such as H 2 , O 2 or Cl 2 , which are likely to harm the cell (Merrill et al., 2005) . Optogenetics may enable a non-contact stimulation of specific cell types in the arterial wall for prolonged periods of time and without these limitations.
In 2015, a Cl À -selective and H + -impermeable ChR2 mutant was identified and termed iChloC (Wietek et al., 2015) . 
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https://doi.org/10.1111/bph.14183 Figure S1 Effects of [KCl] e on the tension of rings of various artery types isolated from ChR2(H134R)-SM mice. Mean tension versus [KCl] e relationships for the different artery types (aortic, A, (N=20, n=32); mesenteric, B, (N=5, n=11) and pulmonary, C, (N=5, n=11)). The curves through the filled symbols represent the best fit of the data with Eq. 5. Figure S2 Ca V channel currents in isolated aortic VSMCs A.
Representative whole-cell Ca V channel currents obtained from aortic VSMCs isolated from ChR2(H134R)-SM mice in response to the stimulation protocol shown in the top panel. For clarity, only the currents elicited every 20 mV are displayed. B. Mean steady-state activation (N=8, n=15) and inactivation (N=7, n=12) curves for Ca V channels measured in aortic VSMCs. Smooth curves represent the fit of the data using Eq. 3 and 4 (activation and inactivation, respectively). Grey bar highlights the range of V m that intact VSMCs can experience as a result of ChR2(H134R)-mediated depolarisations. C. Mean whole-cell Ca V currents versus V m relationships in the absence (N=8, n=15) or presence of 1 μM nifedipine (Nif) which was either kept in the dark (N=5, n=9) or exposed to blue light (2.4 mW/mm2) for 10 min (light conditioned) (N=6, n=20), as indicated. Curves through symbols represent the best fit of the data with Eq. 3. Figure S3 Effects of noradrenaline on the tension of aortic rings isolated from ChR2(H134R)-SM mice. Mean tension versus noradrenaline concentration ([NA]) relationship (N=5, n=8). The curve through the filled symbols represent the best fit of the data with Eq. 5. 
